Product image of Lenalidomid Grindeks (Lenalidomide) supplied by GNH India

Lenalidomid Grindeks

Active Ingredient:
Lenalidomide
Origin:
EU

Lenalidomid Grindeks (Lenalidomide)

Lenalidomide, the active ingredient in Lenalidomid Grindeks, is an Immunomodulatory drug (IMiD) presented as an oral formulation for oral use. It is used to treat certain blood cancers, including multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma, in adult patients.

GNH India supplies Lenalidomid Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Grindeks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lenalidomid Grindeks is an immunomodulatory agent indicated for several hematologic malignancies.
  • Multiple myeloma: improves progression‑free survival and overall response rates in patients with relapsed or refractory disease.
  • Myelodysplastic syndromes (MDS): reduces transfusion dependence and delays transformation to acute leukemia.
  • Mantle cell lymphoma: contributes to disease control when used in combination therapy for relapsed cases.

How It Works

  • Lenalidomide binds to cereblon, a component of the E3 ubiquitin ligase complex, altering substrate specificity. This leads to degradation of transcription factors Ikaros and Aiolos, resulting in reduced cytokine production, anti‑angiogenic effects, and induction of apoptosis in malignant plasma cells and other hematologic cancer cells.

Side Effects

Lenalidomid Grindeks may cause a range of adverse reactions.

Common Side Effects

  • Neutropenia: decreased white blood cell count.
  • Thrombocytopenia: reduced platelet levels.
  • Fatigue: persistent tiredness.
  • Diarrhea: loose stools.
  • Rash: skin irritation.
  • Constipation: difficulty passing stool.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in veins.
  • Severe neutropenia: heightened infection risk.
  • Severe thrombocytopenia: increased bleeding risk.
  • Secondary primary malignancies: new cancers.
  • Stevens‑Johnson syndrome: severe skin reaction.
  • Hepatotoxicity: liver enzyme elevation.

Precautions & Warnings

  • Lenalidomid Grindeks requires careful monitoring and specific safety measures.
  • Pregnancy: Category X – contraindicated; ensure effective contraception.
  • Thrombosis risk: assess patient history before initiating therapy.
  • Blood counts: perform regular CBC monitoring to detect cytopenias.
  • Renal impairment: adjust dose in patients with reduced kidney function.
  • Drug interactions: review concomitant medications for potential CYP effects.
  • Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Avoid Interactions

Lenalidomid Grindeks can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): may increase bleeding risk.
  • Strong CYP3A4 inducers (e.g., rifampin): can lower lenalidomide exposure.
  • Thalidomide: additive teratogenic potential.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may exacerbate renal toxicity.
  • Antibiotics (e.g., fluoroquinolones): potential for enhanced myelosuppression.
  • Live vaccines: risk of infection due to immunosuppression.
  • Digoxin: possible alteration of serum levels.

Frequently Asked Questions

Lenalidomid Grindeks is prescribed for adult patients with multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. It belongs to the immunomodulatory drug class and helps control disease progression in these hematologic cancers.

Lenalidomide binds to the cereblon protein within the E3 ubiquitin ligase complex, directing the degradation of specific transcription factors. This action reduces inflammatory cytokine production, inhibits new blood vessel formation, and triggers programmed cell death in malignant cells.

The dosage of Lenalidomid Grindeks is individualized. A qualified prescriber determines the appropriate strength and schedule based on the patient’s condition, disease stage, and laboratory results. No generic dosing regimen is provided here.

Lenalidomid Grindeks is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to known teratogenic risk. Breastfeeding is also not recommended because the drug can be excreted in milk and may harm the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Lenalidomid Grindeks belongs to the immunomodulatory drug class, offering a distinct mechanism compared with proteasome inhibitors or monoclonal antibodies. It is often used in combination regimens and may provide benefits in patients who have progressed on alternative therapies.

Store Lenalidomid Grindeks at ambient temperature, below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Lenalidomid Grindeks is taken orally, usually as a tablet or capsule, with or without food as directed by the prescribing clinician. The exact administration schedule is set by the healthcare professional based on the treatment plan.

The most serious risks include severe neutropenia and thrombocytopenia, which can lead to infection or bleeding, as well as venous thromboembolism and secondary primary malignancies. Patients should be monitored closely for these events throughout therapy.

Lenalidomid Grindeks should not be used by pregnant women, individuals with known hypersensitivity to lenalidomide or its excipients, and patients with uncontrolled severe infections. Clinicians must evaluate each patient’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lenalidomide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT